{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:41:13Z","timestamp":1783982473835,"version":"3.55.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T00:00:00Z","timestamp":1395619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093070","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T03:56:55Z","timestamp":1395719815000},"page":"e93070","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials"],"prefix":"10.1371","volume":"9","author":[{"given":"Mourad","family":"Tighiouart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Rogatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/sim.1229","article-title":"Competing designs for phase I clinical trials: a review","volume":"21","author":"WF Rosenberger","year":"2002","journal-title":"Stat Med"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ting N (2006) Dose Finding in Drug Development. (New York: Springer.","DOI":"10.1007\/0-387-33706-7"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djp079","article-title":"Dose Escalation Methods in Phase I Cancer Clinical Trials","volume":"101","author":"C Le Tourneau","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hon.808","article-title":"Review: new biological insights in early clinical studies","volume":"25","author":"M Maur","year":"2007","journal-title":"Hematological Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/2531628","article-title":"Continual reassessment method: A practical design for phase I clinical trials in cancer","volume":"46","author":"J O'Quigley","year":"1990","journal-title":"Biometrics"},{"key":"ref6","first-page":"164","article-title":"Practical Modifications of the Continual Reassessment Method for Phase I Cancer Clinical Trials","volume":"147","author":"D Faries","year":"1994","journal-title":"Journal of Biopharmaceutical Statistics 4"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/sim.4780141102","article-title":"Some practical improvements in the continual reassessment method for phase I studies","volume":"14","author":"S Goodman","year":"1995","journal-title":"Statistics in Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/sim.4780140909","article-title":"An Extension of the Continual Reassessment Methods Using a Preliminary up-and-Down Design in a Dose Finding Study in Cancer Patients, in Order to Investigate a Greater Range of Doses","volume":"14","author":"S Moller","year":"1995","journal-title":"Statistics in Medicine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s002800050763","article-title":"Practical Implementation of a Modified Continual Reassessment Method for Dose-Finding Trials","volume":"41","author":"S Piantadosi","year":"1998","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"ref10","first-page":"2408","article-title":"An Evaluation of Phase I Clinical Trial Designs in the Continuous Dose-Response Setting","volume":"2399","author":"BE Storer","year":"2001","journal-title":"Statistics in Medicine 20"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9","article-title":"Cancer Phase I clinical Trials: efficient dose escalation with overdose control","volume":"17","author":"J Babb","year":"1998","journal-title":"Statistics in Medicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0167-7152(98)00016-9","article-title":"Optimal Bayesian-feasibile dose escalation for cancer phase I trials","volume":"38","author":"S Zacks","year":"1998","journal-title":"Stat Prob Ltrs"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/sim.2106","article-title":"Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control","volume":"24","author":"M Tighiouart","year":"2005","journal-title":"Stat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1155\/2012\/692725","article-title":"Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control","volume":"2012","author":"M Tighiouart","year":"2012","journal-title":"Journal of Probability and Statistics"},{"key":"ref15","first-page":"10","article-title":"Incorporating a Patient Dichotomous Characteristic in Cancer Phase I Clinical Trials Using Escalation with Overdose Control","volume":"2012","author":"M Tighiouart","year":"2012","journal-title":"Journal of Probability and Statistics"},{"key":"ref16","first-page":"18","article-title":"Escalation with Overdose Control Using Ordinal Toxicity Grades for Cancer Phase I Clinical Trials","volume":"2012","author":"M Tighiouart","year":"2012","journal-title":"Journal of Probability and Statistics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1214\/10-STS333","article-title":"Dose Finding with Escalation with Overdose Control (EWOC) in Cancer Clinical Trials","volume":"25","author":"M Tighiouart","year":"2010","journal-title":"Statistical Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.0006-341X.2000.01177.x","article-title":"Sequential designs for phase I clinical trials with late-onset toxicities","volume":"56","author":"YK Cheung","year":"2000","journal-title":"Biometrics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/sim.4128","article-title":"Dose-finding approach for dose escalation with overdose control considering incomplete observations","volume":"30","author":"A Mauguen","year":"2011","journal-title":"Stat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"DR Cox","year":"1972","journal-title":"Journal of the Royal Statistical Society Series B-Statistical Methodology"},{"key":"ref21","first-page":"1092","article-title":"Equations of State Calculations by Fast Computing Machines","volume":"1087","author":"N Metropolis","year":"1953","journal-title":"Journal of Chemical Physics 21"},{"key":"ref22","first-page":"109","article-title":"Monte Carlo Sampling Methods Using Markov Chains and Their Applications","volume":"97","author":"WK Hastings","year":"1970","journal-title":"Biometrika 57"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility","volume":"10","author":"DJ Lunn","year":"2000","journal-title":"Statistics and Computing"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1740774507076934","article-title":"Simultaneously optimizing dose and schedule of a new cytotoxic agent","volume":"4","author":"TM Braun","year":"2007","journal-title":"Clinical Trials"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/sim.4255","article-title":"Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities","volume":"30","author":"MYC Polley","year":"2011","journal-title":"Statistics in Medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/biomet\/92.4.863","article-title":"Coherence principles in dose-finding studies","volume":"92","author":"YK Cheung","year":"2005","journal-title":"Biometrika"},{"key":"ref27","unstructured":"Fedorov V, Flournoy N, Wu Y, Zhang R (2011) Best intention designs in dose-finding studies. Cambridge: Isaac Newton Institute for the Mathematical Sciences."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1740774512469311","article-title":"Small-sample behavior of novel phase I cancer trial designs","volume":"10","author":"AP Oron","year":"2013","journal-title":"Clinical Trials"},{"key":"ref29","unstructured":"Rogatko A, Tighiouart M, Bresee C (2012) Escalation with overdose control. User Guide Web-Based Portal. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/biostatistics.csmc.edu\/ewoc\/\" xlink:type=\"simple\">http:\/\/biostatistics.csmc.edu\/ewoc\/<\/ext-link>."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Klein JP, Moeschberger ML (2003) Survival Analysis. New York: Springer.","DOI":"10.1007\/b97377"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T09:34:59Z","timestamp":1716629699000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093070"}},"subtitle":[],"editor":[{"given":"Sam","family":"Eldabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,24]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093070","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,24]]}}}